← Back to Search

MRI and CEDM for Breast Cancer

N/A

Waitlist Available

Led By Janice Sung, MD

Research Sponsored by Memorial Sloan Kettering Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

Study Summary

This trial will compare how well MRI and CEDM work in finding out how much cancer is left after NAT.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Compare diagnostic accuracy of breast MRI and CEDM

Trial Design

1Treatment groups

Experimental Treatment

Group I: Breast MRI and Contrast Enhanced Mammography (CEDM)Experimental Treatment2 Interventions

Breast MRI and CEDM will be performed within 30 days of one another after neoadjuvant therapy

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Breast Magnetic Resonance Imaging (MRI)

2017

N/A

~130

Contrast Enhanced Mammography (CEDM)

2017

N/A

~130

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor

1,933 Previous Clinical Trials

585,495 Total Patients Enrolled

202 Trials studying Breast Cancer

81,012 Patients Enrolled for Breast Cancer

Janice Sung, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

4 Previous Clinical Trials

2,450 Total Patients Enrolled

Media Library

Breast Magnetic Resonance Imaging (MRI) Clinical Trial Eligibility Overview. Trial Name: NCT03070340 — N/A

Breast Cancer Research Study Groups: Breast MRI and Contrast Enhanced Mammography (CEDM)

Breast Cancer Clinical Trial 2023: Breast Magnetic Resonance Imaging (MRI) Highlights & Side Effects. Trial Name: NCT03070340 — N/A

Breast Magnetic Resonance Imaging (MRI) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03070340 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment presently open to new participants?

"According to clinicaltrials.gov, this specific medical trial is no longer open for enrollment as it was last modified on March 16th 2022. However, there are 1404 other studies that are actively seeking participants at the moment."

Answered by AI

How many research facilities are presently conducting this clinical trial?

"Currently, the clinical trial is accepting participants from 5 different medical centres which are located in Montvale, Harrison and New york as well as other locations. To reduce your travel burden while participating in this study, it may be wise to choose a nearby site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Comparison of MRI and CEDM to Evaluate Treatment Response Before Surgery

2017. "Comparison of MRI and CEDM to Evaluate Treatment Response Before Surgery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03070340.